medigraphic.com
ISSN 1560-4381 (Print)

2016, Number 3

<< Back Next >>

Correo Científico Médico 2016; 20 (3)

Dengue and non-steroidal anti-inflammatory drugs: an observational study

Valarezo-Sevilla D, Pazmiño-Martínez A, Sarzosa-Terán V, Acuña SP

Language: Spanish
References: 11
Page: 531-538
PDF size: 299.32 Kb.


ABSTRACT

Introduction: dengue is an infectious disease caused by the dengue virus consisting of four serotypes. In Ecuador about 70% of the land area has the favorable environmental conditions for breeding of Aedes aegypti vector transmitting the virus.
Objective: to describe the treatment received by patients hospitalized with dengue in a basic hospital.
Methods: a retrospective observational, descriptive study, based on medical records of hospitalized patients diagnosed with dengue in Internal Medicine Basic Hospital, Jipijapa (Manabi-Ecuador) during November 2010 - April 2012 was done.
Results: the study included 36 adult patients, 21 males (58.3%) and 15 women (41.7%). Of the total group, 16 patients corresponding to 44.44% (CI 27.94% - 61.90%) received only paracetamol, 17 patients corresponding to 47.22% (CI 30.41% - 64.51%) received a combination of metamizol and paracetamol. The remaining three patients received other combinations. The four patients who had classic dengue with hemorrhagic manifestations (DMH) belong to the group who received paracetamol and metamizol corresponding to 23.53% of that combination and 11.11% of all patients studied and statistically significant p = 0 04.
Conclusions: the authors concluded that due to the limited information published, there are not enough studies regarding the use of Non-Steroidal Anti-Inflammatory Agents in patients with dengue and the few who have made the results are not consistent.


REFERENCES

  1. WHO. Dengue haemorrhagic fever: diagnosis, treatment, prevention and control. 2da Ed. Geneva: WHO; 1997. [citado 26 mar 2015] Disponible en: http://whqlibdoc.who.int/publications/1997/9241545003_eng.pdf

  2. Wong A. A reappraisal of antipyretic and analgesic drugs. WHO Pharmaceuticals Newsletter. 2002[citado 16 may 2012]; 1:1-18. Disponible en: http://apps.who.int/medicinedocs/pdf/s2253e/s2253e.pdf

  3. WHO. Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: WHO; 2009. [citado 4 sep 2010]. Disponible en: http://www.who.int/tdr/publications/documents/dengue-diagnosis.pdf

  4. Guías de atención para enfermos de dengue en la región de las Américas. La Paz-Bolivia: OPS; 2010[citado 17 jul 2011].Disponible en: http://www.ops.org.bo/textocompleto/ndeng31482.pdf

  5. Martínez RA. Tratamiento del dengue durante su etapa aguda: revisión sistemática de la literatura. Infect. 2008[citado 16 may 2012]; 12(4):277-286. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0123-93922008000400006&lng=es&nrm=iso&tlng=es

  6. WHO. Handbook for clinical management of dengue. Geneva: WHO; 2012[citado 7 abr 2015]. Disponible en: http://apps.who.int/iris/bitstream/10665/76887/1/9789241504713_eng.pdf

  7. Malagon JN, Padilla JC, Rojas Álvarez DP. Guía de Atención Clínica Integral del paciente con

  8. Dengue. Infectio. 2011[citado 18 nov 2014]; 15(4):293-301. Disponible en: http://www.acin.org/acin/new/Portals/0/Templates/Guia Dengue 2011.pdf

  9. Suárez Ognio L, Arrasco J, Casapía M, Sihuincha M, Ávila J, Soto G, et al. Factores asociados a dengue grave durante la epidemia de dengue en la ciudad de Iquitos, 2010 – 2011. Rev Peruana Epidemiol. 2011[citado 18 nov 2014]; 15(1):17-23.Disponible en: http://www.redalyc.org/pdf/2031/203119644003.pdf

  10. Díaz Quijano FA, Villar Centeno LA, Martínez Vega RA. Efecto de la administración temprana de dipirona sobre la gravedad del dengue en una cohorte prospectiva. Enferm Infecc Microbiol Clin. 2005[citado 7 abr 2015]; 23(10):593-597. Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=13081567&pident_usuario=0&pcontactid=&pident_revista=28&ty=67&accion=L&origen=zonadelectura&web=www.elsevier.es&lan=es&fichero=28v23n10a13081567pdf001.pdf

  11. Rojas-Rosaldo A, Toledo-Almaraz R, Rojas-Rosaldo MS. Indicación del metamizol en pacientes con dengue clásico y dengue hemorrágico. Med Int Mex 2006; 22:297-301. [citado 2012 May 22]. Disponible en: http://www.medigraphic.com/pdfs/medintmex/mim-2006/mim064i.pdf




2020     |     www.medigraphic.com